← SynDRA
FLUDARABINE PHOSPHATE
SynDRA canonical compound SYN0021754 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | RRM1 |
| Mechanism of action | DNA repair enzyme inhibitor |
| Indication | chronic lymphocytic leukemia (CLL) |
| Disease area | hematologic malignancy |
All known targets
- POLA1
- RRM1
- POLE
- RRM2
- POLD1
- POLD4
- PRIM2
- PRIM1
- POLE3
- POLE2
- RRM2B
- POLD3
Mechanisms of action (all sources)
- Purine antagonist
- DNA synthesis inhibitor
- DNA repair enzyme inhibitor
- POLA1 INHIBITOR
- DNA polymerase (alpha/delta/epsilon) inhibitor
- POLD4 INHIBITOR
- POLD3 INHIBITOR
- POLD1 INHIBITOR
- POLD2 INHIBITOR
- POLE INHIBITOR
- POLA2 INHIBITOR
- PRIM1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRA1A
- HRH3
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR1A
- HRH2
- ADRA2A
- HRH1
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
- CA1
- CA2
- CCKAR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Nucleic Acid Synthesis Inhibitors
- Antineoplastic Agents
- Antimetabolites
- Antimetabolites, Antineoplastic
- Immunologic Factors
- Immunosuppressive Agents
- Noxae
- Nucleoside Metabolic Inhibitor
ATC classes
Cross-references
Synonyms
- FLUDARA
- OFORTA
- fludarabine 5'-monophosphate
- fludura
- fludara
- 2-F-ara-AMP
- Fludarabine 5'-monophosphate
- 2-f-ara-amp
- Fludarabine monophosphate
- NSC-312887
- NSC-328002
- Fludara
- Oforta
- Gedeptin
- Fludura
- 2-Fluoro-ARA AMP
- Fludarabine (phosphate)
- FAMP
- UNII-1X9VK9O1SC
- NSC 312887
- C10H13FN5O7P
- 2-Fluoroadenine arabinoside 5'-monophosphate
- NSC 328002
- 1X9VK9O1SC
- 9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate
- Fludarabine Phosphate (Fludara)
- 9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate
- CHEBI:63599
- 9-beta-D-Arab
- fludarabine-phosphate
- Fludarabine
- F-Ara-A
- 2-FLUORO-ARA-A
- Fludarabine [INN]
- 9-beta-D-Arabinofuranosyl-2-fluoroadenine
- Fludarabinum
- NSC-118218
Reported adverse events
- P
- Evans syndrome
- Erythema multiforme
- Infection
- Myelosuppression
- Neoplasm
- Pneumonia
- Stevens-Johnson syndrome
- Skin toxicity
Look up FLUDARABINE PHOSPHATE in the interactive SynDRA portal →